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Abstract
Rationale—Treatment of sinus node disease with regenerative or cell-based therapies will 
require a detailed understanding of gene regulatory networks in cardiac pacemaker cells (PCs).
Objective—To characterize the transcriptome of PCs using RNA sequencing, and to identify 
transcriptional networks responsible for PC gene expression.
Methods and Results—We used laser capture micro-dissection (LCM) on a sinus node 
reporter mouse line to isolate RNA from PCs for RNA sequencing (RNA-Seq). Differential 
expression and network analysis identified novel SAN-enriched genes, and predicted that the 
transcription factor Islet-1 (Isl1) is active in developing pacemaker cells. RNA-Seq on SAN tissue 
lacking Isl1 established that Isl1 is an important transcriptional regulator within the developing 
SAN.
Conclusions—(1) The PC transcriptome diverges sharply from other cardiomyocytes; (2) Isl1 is 
a positive transcriptional regulator of the PC gene expression program.
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INTRODUCTION
Pacemaker cells (PCs) within the sinoatrial node (SAN) generate the electrical impulse that 
initiates each heartbeat. Sinus node dysfunction (SND), characterized by loss of PCs and 
SAN fibrosis, is a common but poorly understood disease. With the advent of cellular 
reprogramming technology,1, 2 there is increasing interest in understanding gene regulatory 
networks in PCs, both to improve our understanding of SND and to facilitate novel therapies 
such as biological pacemakers and SAN regeneration.
Transcription factors important for SAN development and function have been identified, 
including Tbx18,3 Tbx3,4 Shox2,5 and Isl1.6, 7 Efforts to reprogram non-PCs into PCs have 
employed some of these SAN transcription factors,8–10 even though their downstream 
transcriptional networks have not been fully elucidated.
Although these efforts are highly promising, there have been no genome-wide transcriptome 
comparisons of putatively reprogrammed PC-like cells with bona fide PCs, largely because 
of the absence of PC transcriptome data. Transcriptional profiling of PCs presents special 
challenges because of the lack of specific molecular markers, the small size of the 
developing SAN, and the interdigitation of PCs with non-PCs in the SAN. At present, the 
lack of transcriptome data from PCs remains a barrier to further progress in understanding 
SAN biology, and to assessing and improving the fidelity of PC reprogramming technology.
METHODS
Laser capture microdissection
Embryos or hearts were removed intact, washed with cold PBS, and immediately embedded 
in OCT and stored at −20 °C until sectioning. Tissue was sectioned at a thickness of 8 
microns onto membrane-coated slides (MembraneSlide NF 1.0 PEN, Zeiss Microscopy, 
Gottingen, Germany). For laser capture, slides were thawed to room temperature until 
evaporation of moisture (approximately 1 minute), placed on the microscope stage of a 
PALM Micro-Beam inverted microscope with LCM capability (Zeiss). The sinus node 
tissue was identified visually and outlined manually with the microscope user interface 
(Online Video II). Laser power and catapult energy were optimized prior to the experiment 
and varied from experiment-to-experiment. After each experiment, sections were stained 
with DAPI and anti-Hcn4, mounted, and visualized to confirm accurate dissection of the 
region of interest.
A detailed methods section is available online.
RESULTS
Laser capture micro-dissection of cardiac pacemaker cells for RNA sequencing
Hcn4-GFP BAC transgenic mice exhibited high-level GFP expression in the sinoatrial node 
(SAN) and venous pole at E12.5, with further restriction of expression to the SAN at P0 and 
in the adult heart (Figure 1A).11 GFP expression was complementary to Connexin-40, a 
marker of working atrial myocytes, and isolated adult GFP+ cells showed morphology 
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typical of PCs and exhibited spontaneous beating (Figure 1B, Online Video I). We isolated 
SAN tissue and right atrial (RA) myocardium by laser capture micro-dissection (LCM) on 
unfixed, unstained cryosections from flash frozen Hcn4-GFP hearts harvested at E14.5, P4, 
and P14 (Figure 1C, Online Video II). The SAN is heterogeneous and includes non-PC cells 
such as fibroblasts, endothelial cells, and atrial cardiomyocytes. To optimize enrichment for 
PCs, we selected regions of interest for LCM within the SAN head (near the SAN artery) 
that contained purer populations of PCs (Online Figure I). Such regions within the SAN, as 
well as neighboring RA regions, were excised from 6 consecutive embryonic heart sections 
and pooled to generate total RNA. We repeated the LCM experiment for three different 
embryos for each time point to generate 18 independent RNA samples, reflecting 3 
biological replicates for each tissue and time point (Online Table I). Each sample was 
processed separately for RNA-sequencing (RNA-seq) as described in the online methods 
section.
Differential expression analysis
Differential expression (DE) analysis of RNA-seq data between SAN and RA tissue samples 
revealed hundreds of DE genes at each time point (Online Table II). Known SAN-associated 
genes Hcn4, Tbx3, Shox2, Tbx18, and Bmp4 were all enriched in the SAN tissue, while RA-
associated genes Nkx2-5, Nppa, and Gja1 were enriched in the RA samples (Online Figure 
I), demonstrating the fidelity of tissue isolation. Of note, the core cardiac transcription 
factors Gata4, Mef2c and Tbx5, were not differentially expressed between SAN and RA. 
We also found numerous genes enriched in the SAN tissue that had not been previously 
associated with PCs (Figure 2A, Online Table II). Gene Ontology terms (GO) associated 
with SAN-enriched genes included Bmp and Wnt signaling pathways at E14.5, and neuronal 
development and function at later time points (Figure 2A, Online Table III). Conversely, 
RA-enriched genes were associated with GO terms that included conduction, contractile 
apparatus, and cell junction formation (Figure 2B, Online Table III). While a core set of 
genes in each tissue type exhibited DE at all time points examined (Online Table IV), there 
was considerable change over time within the DE gene set, highlighting the dynamic nature 
of expression during SAN development. Hierarchical clustering of SAN and RA samples 
revealed that biological replicates clustered together, and that, as differentiation progressed, 
SAN samples were more similar to each other than they were to the RA samples (Online 
Figure II).
Network analysis
We employed weighted gene correlation network analysis (WGCNA) to partition the RA 
and SAN transcriptomes into modules exhibiting correlated gene expression (Online Figure 
III, Online Table V). Most time points of specific tissue were associated with at least one 
highly active module. Module 1 (M1) exhibited highest activity at E14.5, a critical period 
for SAN morphogenesis and PC differentiation (Figure 2C). M1 contained several 
previously identified SAN-enriched transcription factors, including Tbx18, Shox2, and Isl1, 
while Tbx3 clustered with Hcn4 and Hcn1 in M7. Of the factors in M1, Isl1 had the highest 
level of DE as well as high transcript abundance early in SAN development (Figure 2D).
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Conditional selection of Isl1 after second heart field differentiation
To test for a requirement of Isl1 in the PC gene expression program, we crossed Isl1loxp/loxp; 
CAG-Cre/Esr1 with Isl1loxp/loxp; Hcn4-GFP and injected intra-peritoneal tamoxifen at E10.5 
(Figure 3A). This strategy generated a global deletion of Isl1 after second heart field 
differentiation, which circumvented the early embryonic lethality associated with Isl1 loss of 
function. Cre+;Hcn4-GFP+ embryos were recovered at Mendelian ratios at E12.5, 
indicating that loss of Isl1 after second heart field differentiation did not lead to rapid 
embryonic demise. SAN Hcn4-GFP expression was reduced but readily detectable in Cre+ 
embryos (Figure 3B).
We then performed LCM on Cre+ and Cre− embryonic SAN at E12.5. Each sample was 
pooled from approximately 9 SAN sections per embryo, and we used 7 different embryos (3 
for Cre+ group and 4 for Cre− group, Figure 3B). Quantitative PCR performed on amplified 
cDNA prior to RNA-Seq library preparation could not detect Isl1 transcript in the samples 
from Cre+ embryos, a finding confirmed by the absence of RNA-Seq reads mapped to the 
floxed portion of Isl1 (Online Figure IV).
SAN transcriptome in the absence of Isl1
590 genes exhibited DE between Cre+ and Cre− RNA samples, of which 65% were 
downregulated in SAN tissue lacking Isl1 (Figure 3C, Online Table VI). Among the genes 
enriched in SAN tissue vs. RA at E14.5, 18% were downregulated after deletion of Isl1 
(odds ratio (OR) = 14, p=1.1 × 10−88, compared to non-DE genes), indicating a positive role 
for Isl1 in the PC-specific gene expression program. Of genes with established roles in SAN 
development and PC function, Tbx3, Hcn4, Hcn1, and Cacna1g were all significantly 
decreased after deletion of Isl1, while expression of other cardiac and SAN TFs including 
Nkx2.5, Gata4, Mef2C, Tbx5, and Tbx18 were not significantly changed (Figure 3D). 
Conversely, 9% of RA-enriched genes (including Nppa, Gja1, Gja5, and Scn5a) were 
upregulated in SAN after loss of Isl1 (OR = 10, p=9.6 × 10−35), suggesting a secondary role 
for Isl1 in repressing a differentiation program associated with working myocardium.
Network and motif analysis on dysregulated genes
Assessment of individual network activity after loss of Isl1 function showed that M7 
(containing Hcn4 and Tbx3), followed by M1 (containing Tbx18, Shox2 and Isl1), were the 
most reduced in overall activity (Online Figure VI). Conversely, the only modules that 
exhibited increased activity after loss of Isl1, M3 and M9, were associated with increased 
activity in RA. To relate these global changes in expression to loss of Isl1 function, we 
searched for Isl1 binding sites within introns, untranslated regions, and 10 kb upstream of 
the transcriptional start sites of genes that were downregulated after loss of Isl1, and 
compared the frequency of occurrence of these sites to genes that were unaffected by Isl1 
deletion. This analysis showed highly significant enrichment (p = 0.0003) of Isl1 binding 
sites among the genes downregulated after Isl1 deletion, suggesting a role for Isl1 as a direct 
transcriptional activator in the developing SAN (Figure 4A, Online Figure VI). Examples of 
putative Isl1 binding sites in Tbx3 and Hcn4 regulatory regions are shown in Online Table 
VII. Because of the limiting number of pacemaker cells in each embryonic heart, it was not 
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possible to test these sites directly using chromatin immunoprecipitation. Conversely, we did 
not observe enrichment of Isl1 binding sites near the genes upregulated after Isl1 deletion, 
suggesting that Isl1 may not function primarily as a direct transcriptional repressor of these 
genes, but may suppress the atrial gene expression program indirectly (Figure 4B, Online 
Figure V).
Sensitivity analysis
Because inadvertent contamination of a Cre+ SAN sample with non-PC myocytes would 
bias our analysis towards the observed effects, we assessed our SAN samples for the 
presence of outliers. We found that one of the three Cre+ samples consistently exhibited 
more dramatic changes in gene expression at more diverse loci than the other two samples, 
raising the possibility of either contamination by non-PC myocytes or simply biological 
variation. To insure the robustness of our findings, we repeated our differential expression 
analysis and motif analysis after excluding this outlier sample and observed no significant 
changes in our results (Online Table VII, Online Figure VI).
DISCUSSION
Here, we present a comprehensive transcriptional analysis of mammalian PCs by deep 
sequencing SAN tissue obtained with LCM. While PCs and RA myocytes share core 
transcriptional machinery, mature PCs have adopted a distinct transcriptional program, 
consistent with morphological and electrical phenotypes exhibited by PCs. Our dataset 
highlights dynamic changes in PC gene expression associated with differentiation and 
maturation, and reveals a central role of Isl1 in establishing the PC gene program.
Establishment and utility of SAN-specific gene networks
Knowledge of the SAN transcriptome is a prerequisite to understanding the unique 
properties of this specialized cell type and its disruption in the setting of disease. In addition, 
the description of the major regulators and networks activated and repressed in the SAN 
provides a foundation for studies aimed at regulating SAN cell fate. Because of the difficulty 
of isolating pure PC RNA, there has been no dataset to use for comparison of putatively 
reprogrammed PCs with endogenous PCs. Because some non-PC cardiomyocytes can 
exhibit automaticity with PC-like action potentials,12, 13 and many SAN-associated genes 
such as Hcn4 exhibit dynamic expression outside the SAN,14 it is ideal to have a 
characteristic transcriptome as a means to determine the degree of fidelity during 
reprogramming.15
Our SAN expression profile can provide such a benchmark for investigators attempting to 
derive PCs from non-PCs and will permit more precise characterization of putatively 
reprogrammed cells. Analysis of specific gene sets with discordant expression between bona 
fide PCs and reprogrammed PCs may lead to targeted refinements of current methods. In 
addition, by quantifying changes in SAN gene expression during development, our dataset 
may suggest ways to promote maturation of incompletely reprogrammed cells.
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Role of Isl1 in establishing the SAN gene network
Isl1 is required for second heart field development in mice16 and for SAN development in 
zebrafish.6 Although Isl1 expression and function in mouse PCs has been described 
previously,7, 17 its transcriptional role in the SAN remains unknown. Our loss of function 
data demonstrated that SAN-enriched genes were strongly overrepresented among the genes 
downregulated after Isl1 disruption, suggesting that Isl1 is required to generate the SAN-
specific gene expression program. Furthermore, we observed significant enrichment of Isl1 
binding sites within and around downregulated genes, providing strong evidence that Isl1 is 
a direct transcriptional activator of gene expression in PCs.
We also observed upregulation of genes associated with RA myocardium in the SAN after 
deletion of Isl1, including Nppa, Scn5a, Gja1, and Gja5. However, we did not observe 
enrichment of Isl1 binding sites near the upregulated genes, suggesting that Isl1 functions 
indirectly to block the RA myocyte gene expression in the SAN. Tbx3 is an established 
negative regulator of the atrial myocyte gene expression program4 and was found in our 
analysis to be highly downregulated after deletion of Isl1. One possibility is that 
upregulation of RA genes after Isl1 deletion is mediated in part by downregulation of Tbx3 
(Figure 4C). This model situates Isl1 as a key transcriptional activator in PCs with a major 
role in establishing the SAN-specific gene expression program. As the scope of the present 
study is limited to expression analysis, further work will be required to delineate the 
functional and developmental roles of Isl1 in sinoatrial node, and to validate putative direct 
transcriptional targets. In addition, the potential of Isl1 to augment PC derivation or 
reprogramming has yet to be fully explored. Our analysis suggests that multifactor 
reprogramming using Isl1 in combination with other cardiac and/or SAN transcription 
factors may be a fruitful approach.
Acknowledgments
We thank the Gladstone Genomics Core, the UCSF Center for Advanced Technology, and the Gladstone 
Bioinformatics Core for assistance with RNA library preparation, RNA sequencing, and initial sequence analysis, 
respectively. LCM was performed at the UCSF Laboratory for Cell Analysis.
SOURCES OF FUNDING
The authors were funded by the NIH/NHLBI (K08 HL101989 to V.V.; K08 HL093861, DP2 HL123228, and U01 
HL107440-03 to R.C.D.; R01 HL057181, P01 HL089707 U01 HL100406, and U01 HL098179 to D.S.), the AHA 
(14BGIA20490269 to V.V.), the Younger Family Foundation, the Roddenberry Foundation, and the California 
Institute for Regenerative Medicine (to D.S.).
Nonstandard Abbreviations and Acronyms
SAN sinoatrial node
RA right atrium
PC pacemaker cell
LCM laser capture micro-dissection
GFP green fluorescent protein
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M gene expression module
Cre Cre Recombinase
DE Differential expression
GO Gene ontology
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Novelty and Significance
What Is Known?
• Cardiac pacemaker cells (PCs) in the sinoatrial node (SAN) have a distinct gene 
expression program that underlies their unique functional properties, but are 
difficult to isolate in sufficient quantity and with adequate purity required for 
expression profiling.
• Non-PC myocytes can be reprogrammed to exhibit PC-like behavior using SAN 
transcription factors, with varying efficiency and uncertain fidelity.
What New Information Does This Article Contribute?
• Pure SAN tissue was isolated at mid-development, the perinatal period, and 
after maturation for comprehensive expression profiling using RNA sequencing.
• Differential expression analysis of SAN tissue and right atrial tissue uncovered 
numerous SAN-enriched genes not previously associated with PCs.
• RNA sequencing of SAN tissue in the absence of the transcription factor Islet-1 
(Isl1) showed that Isl1 plays an important role in establishing the PC gene 
expression program during heart development.
The regeneration of sinoatrial node (SAN) or the creation of biological pacemakers using 
cellular reprogramming are promising new approaches to the treatment of sinus node 
disease (SND). Further development of these therapies will require a detailed 
understanding of transcriptional networks in specialized cardiac pacemaker cells (PC). 
However, these cells are difficult to characterize because they are few in number, they 
lack of specific molecular markers, and they are interspersed among non-PC cells. In this 
study, we used laser capture microdissection to isolate purer populations of PCs from 
embryonic, perinatal, and postnatal SAN for RNA sequencing. Analysis of RNA 
sequencing data uncovered numerous genes expressed in SAN that were not previously 
associated with PCs. Based on high differential expression, high absolute expression, and 
a weighted gene correlation network analysis, the transcription factor Isl1 was predicted 
to regulate PC-specific gene expression. RNA-Seq on SAN tissue lacking Isl1 confirmed 
this prediction and established Isl1 as an important transcriptional regulator within the 
developing SAN. The results of this study could from the basis of further mechanistic 
investigations into the gene regulatory networks active in the SAN and future 
translational work on SND.
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Figure 1. Laser Capture Micro-Dissection of Sinoatrial Node Pacemaker Cells from Hcn4-GFP 
BAC Transgenic
(A) Whole-mount images of embryonic day (E) 12.5 hearts (top, left), post-natal day 0 (P0, 
bottom, left), and adult right atrium (bottom right) showed expression of Hcn4-GFP, 
compared to in-situ hybridization for Hcn4 (top, right). Arrows denote sinoatrial node 
(SAN). At the adult stage, GFP+ cells were present in the mature SAN, located in the inter-
caval groove between the inter-atrial septum (ias) and right atrium (ra). (B) 
Immunohistochemistry on adult SAN from Hcn4-GFP hearts showing complementary 
expression of GFP and Connexin-40 (Cx40) (arrow denotes SAN artery). Isolated Hcn4-
GFP+ cells (top, right), were Hcn4+ by immunocytochemistry (bottom, left – high 
magnification inset shows Hcn4 immunostaining at cell membrane) and were positive for 
the myocyte marker α-actinin (bottom, right). (C) Unfixed, unstained sections from Hcn4-
GFP hearts were used for laser capture microdissection (LCM) of SAN and RA at time 
points indicated. Schematic depictions of the SAN and RA are shown for corresponding 
sections before or after LCM. Arrows denote SAN artery; ‘*’ denotes the excised SAN 
region and ‘**’ denotes excised right atrial tissue; svc, superior vena cava; ivc, inferior vena 
cava. Scalebars = 200 μM unless otherwise indicated.
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Figure 2. Comparative Expression Analysis of SAN and RA
(A) Venn diagram showing overlap of SAN-enriched genes at E14.5, P4, and P14 using a 
false discovery rate cutoff of 0.05. Selected enriched gene ontology terms with example 
genes are shown for each time point. (B) Similar Venn diagram as (A), but for RA-enriched 
genes. (C) Weighted gene correlation network analysis (WGCNA) identified 11 highly 
correlated modules within SAN/RA data set. Module eigengene activity was computed for 
each module for each of the 18 SAN/RA expression time points. Color key indicates activity 
scale. (D) Expression of SAN-enriched transcription factors within Module 1 at E14.5. 
Transcript levels are shown on the X-axis and differential expression (SAN vs RA) on the 
Y-axis. Abbreviations: SAN, sinoatrial node; RA, right atrium.
Vedantham et al. Page 11
Circ Res. Author manuscript; available in PMC 2016 February 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. SAN Transcriptome After Isl1 Deletion
(A) Strategy to obtain RNA from SAN tissue lacking Isl1. (B). Top row: 
Immunohistochemistry of E12.5 SAN in Cre− embryos, with intact Isl1 expression (left) in 
comparison to Cre+ embryos (right) which lack Isl1. DAPI staining indicates nuclei. Bottom 
row: adjacent sections from Cre+ E12.5 SAN lacking Isl1. Left, uncut, and right, after laser 
capture microdissection. Scalebars = 100 μM (C) Venn diagrams showing statistically 
significant overlap of genes enriched in SAN (top) or RA (bottom) at E14.5 with genes that 
were downregulated (top) or upregulated (bottom) after Isl1 deletion. (D) Scatterplot 
showing that Isl1 results in downregulation of SAN-enriched genes and upregulation of RA-
enriched genes. Abbreviations: rcv, right cardinal vein; ra, right atrium; NS, non-significant.
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Figure 4. Inferring Isl1 Function in Cardiac Pacemaker Cells
(A) For motif analysis on Isl1 binding sites, regions up to 10kb upstream of the 
transcriptional start site, introns, and untranslated regions for genes downregulated after Isl1 
deletion were included in the query set. A null set was defined as genes that were not 
differentially expressed. The histogram shows a distribution of medians of 10,000 samples 
drawn from the null set by bootstrap sampling. The arrow denotes the observed frequency of 
Isl1 binding sites among genes downregulated after Isl1 deletion. (B) Similar motif analysis 
to (A), where the arrow denotes the observed frequency of Isl1 binding sites at genes 
upregulated after loss of Isl1. (C) A model for Isl1 transcriptional activity in the SAN. A 
solid line indicates a direct transcriptional relation; dashed lines indicate hierarchical 
relationships based on expression analysis only (may be direct or indirect).
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